Review
Copyright ©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Respirol. Jul 28, 2015; 5(2): 93-101
Published online Jul 28, 2015. doi: 10.5320/wjr.v5.i2.93
Collagen vascular disease-associated interstitial lung disease
Christine L Vigeland, Maureen R Horton
Christine L Vigeland, Maureen R Horton, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, United States
Author contributions: Vigeland CL and Horton MR contributed equally to this work.
Supported by the Osborne Family Research Fund.
Conflict-of-interest statement: Dr. Christine L Vigeland is an employee of the Johns Hopkins University School of Medicine. Dr. Maureen R Horton is an employee of the Johns Hopkins University School of Medicine and has received research funding from NIH, FAMRI, American Asthma Foundation, Hoffman-Roche, and InterMune.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Maureen R Horton, MD, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, 1830 East Monument Street, Fifth Floor, Baltimore, MD 21205, United States. mhorton2@jhmi.edu
Telephone: +1-410-6145445 Fax: +1-410-9550299
Received: October 20, 2014
Peer-review started: October 21, 2014
First decision: November 27, 2014
Revised: December 19, 2014
Accepted: March 4, 2015
Article in press: March 5, 2015
Published online: July 28, 2015
Core Tip

Core tip: Interstitial lung disease (ILD) is a significant manifestation of collagen vascular diseases due to its association with increased morbidity and mortality. Thus it is important for clinicians to consider and be able to recognize collagen vascular disease-associated ILD and initiate appropriate treatment. This review will discuss the clinical features, histologic findings, and treatment options of collagen vascular disease-associated ILD.